ZAMBROWICZ BRIAN P
Insider CIK 1226231 · LXRX EVP, Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 21,250 | — | $0 | 21,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 20,000 | — | $0 | 60,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 21,500 | — | $0 | 43,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 20,000 | — | $0 | 296,889 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 21,500 | — | $0 | 276,889 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2014-02-28 | 2014-03-03 | 18,186 | $1.92 | $34.9K | 278,703 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 21,250 | — | $0 | 255,389 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 340,000 | — | $0 | 340,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 85,000 | — | $0 | 85,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 21,500 | — | $0 | 64,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 21,250 | — | $0 | 42,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-02-28 | 2013-03-01 | 11,692 | $1.98 | $23.2K | 234,139 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 21,250 | — | $0 | 224,331 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 21,500 | — | $0 | 245,831 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 80,000 | — | $0 | 80,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 320,000 | — | $0 | 320,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-01-31 | 2013-02-04 | 42,100 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-01-31 | 2013-02-04 | 42,100 | — | $0 | 216,580 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-01-31 | 2013-02-04 | 13,499 | $2.11 | $28.5K | 203,081 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2012-02-28 | 2012-03-01 | 21,250 | — | $0 | 63,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2012-02-28 | 2012-03-01 | 5,621 | $1.78 | $10.0K | 174,480 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2012-02-28 | 2012-03-01 | 21,250 | — | $0 | 180,101 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 86,000 | — | $0 | 86,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 344,000 | — | $0 | 344,000 | SEC↗ |